Back HIV/Hepatitis Coinfection HIV/HBV/HCV Triple Infection


CROI 2014 & EASL 2014: Treating Hepatitis B and C in HIV+ People Reduces Liver Disease

Effective antiviral treatment that suppresses hepatitis B virus (HBV) repliaction or eradicates hepatitis C virus (HCV) can lower the risk of developing advanced liver disease including cirrhosis, hepatocellular carcinoma, and decompensation in people with HIV and viral hepatitis coinfection, according to studies presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI) and EASL International Liver Congress.


Read more:

AIDS 2012: Triple Infection with HBV Promotes HCV Clearance in People with HIV

altCompetition between hepatitis B virus (HBV) and hepatitis C virus (HCV) in HIV positive people with triple infection appears to promote spontaneous HCV clearance, but lower CD4 T-cell counts and greater liver inflammation reduce the likelihood of clearance, Chinese researchers reported at the XIX International AIDS Conference (AIDS 2012) last month in Washington, DC.

Read more:

HIV-HCV Coinfected Individuals in Italy Are Likely to also Have Occult HBV

Among HIV positive participants in the Italian ICONA cohort, 15% had detectable hepatitis B virus (HBV), and this was almost 3 times more common among patients who were also infected with hepatitis C virus (HCV), according to a study published in the advance online edition of the journal Infection.

Read more: